444 results on '"Matias-Guiu, Jordi A."'
Search Results
2. Leptin haploinsufficiency exerts sex-dependent partial protection in SOD1G93A mice by reducing inflammatory pathways in the adipose tissue
3. Neural basis of fatigue in post-COVID syndrome and relationships with cognitive complaints and cognition
4. Pilot Trial on Awake Surgery for Low-Grade Arteriovenous Malformations in Speech Area and Systematic Review of the Literature
5. Predicting changes in brain metabolism and progression from mild cognitive impairment to dementia using multitask Deep Learning models and explainable AI
6. Cognitive dysfunction characteristics of multiple sclerosis with aging
7. Emotional processing in patients with single brain damage in the right hemisphere
8. Thermosensitive chitosan-based hydrogel: A vehicle for overcoming the limitations of nose-to-brain cell therapy
9. Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome
10. GA-MADRID: design and validation of a machine learning tool for the diagnosis of Alzheimer’s disease and frontotemporal dementia using genetic algorithms
11. Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach
12. The effects of the COVID-19 pandemic on neuropsychiatric symptoms in dementia and carer mental health: an international multicentre study
13. Predominance of visuoconstructive impairment after mild COVID-19?
14. Comparison of the Diagnostic Accuracy of Five Cognitive Screening Tests for Diagnosing Mild Cognitive Impairment in Patients Consulting for Memory Loss.
15. Identification of the main components of spontaneous speech in primary progressive aphasia and their neural underpinnings using multimodal MRI and FDG-PET imaging
16. Speech pause distribution as an early marker for Alzheimer’s disease
17. Deep Learning for Predicting Cerebral Metabolism Changes Along the Alzheimer's Disease Continuum
18. Validation technique and improvements introduced in a new dedicated brain positron emission tomograph (CareMiBrain)
19. Diagnosis of Alzheimer's disease and behavioural variant frontotemporal dementia with machine learning‐aided neuropsychological assessment using feature engineering and genetic algorithms
20. Reading prosody in the non-fluent and logopenic variants of primary progressive aphasia
21. Cognitive Processes Underlying Verbal Fluency in Multiple Sclerosis
22. Reading prosody in the non-fluent and logopenic variants of primary progressive aphasia
23. Detection of cerebrospinal fluid biomarkers changes of Alzheimer's disease using a cognitive stress test in persons with subjective cognitive decline and mild cognitive impairment.
24. Diagnosis of Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Spectrum
25. Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial
26. PROGNOSTIC VALUE OF AT(N) CLASSIFICATION IN CSF USING CLUSTERING ANALYSIS
27. 4. An innovative clinical trial designed to evaluate the effects of ACI‐24.060 in Alzheimer’s Disease and in Down syndrome (ABATE Study)
28. Validation of the European Cross‐Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer’s disease and Parkinson’s disease in Spain
29. Cross‐cultural properties of the Cross‐cultural Dementia Screening test and the European Cross‐Cultural Neuropsychological Test Battery
30. Normative Data in Cross-Cultural Neuropsychological Instruments in Spaniards and Colombians Living in Spain
31. FDG-PET-based neural correlates of Addenbrooke’s cognitive examination III scores in Alzheimer’s disease and frontotemporal degeneration
32. Exploring Brain PET Connectivity Data with Machine Learning: A Case Study on Primary Progressive Aphasia
33. A cognitive stress test for prodromal Alzheimer's disease: Multiethnic generalizability
34. Machine learning in the clinical and language characterisation of primary progressive aphasia variants
35. A data‐driven approach to complement the A/T/(N) classification system using CSF biomarkers.
36. Leptin haploinsufficiency exerts sex-dependent partial protection in SOD1G93A mice by reducing inflammatory pathways in the adipose tissue.
37. Assessment tools accuracy for classification and diagnosis of Primary Progressive Aphasia: A systematic review and meta-analysis protocol.
38. Contributors
39. Addenbrooke's Cognitive Examination
40. Evaluation of the Safety and Efficacy of the Therapeutic Potential of Adipose-Derived Stem Cells Injected in the Cerebral Ischemic Penumbra
41. Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis
42. Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease
43. Reading difficulties in primary progressive aphasia in a regular language-speaking cohort of patients
44. Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints
45. Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities.
46. FDG-PET-based neural correlates of Addenbrooke's cognitive examination III scores in Alzheimer's disease and frontotemporal degeneration.
47. Cognitive dysfunction in patients with primary adrenal insufficiency: A systematic review.
48. Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities–focused research
49. Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study
50. A taxonomic approach to cognitive diagnostics is viable and achievable in MS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.